The Board of Directors confirmed a dividend payment of $0.08 per share for the quarter ending June 30, 2026. This distribution remains scheduled for payout on August 28, 2026, for all common shareholders of record by the corrected August 24 date. The company noted that all other details surrounding the dividend declaration remain unchanged from the previous announcement.

Bio-Techne, a global entity specializing in life science reagents and precision diagnostics, maintains a workforce of approximately 3,000 employees across 34 international locations. The firm reported net sales exceeding $1.2 billion during the 2026 fiscal year. Future dividend distributions will continue to be evaluated by the Board on a quarterly basis, subject to ongoing financial performance and market conditions.